Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
J Hum Nutr Diet ; 19(6): 401-19, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17105538

RESUMO

AIM: To update dietetic guidelines based on systematic review evidence on dietary advice to prevent further events in people with existing cardiovascular disease (CVD) (secondary prevention). METHODS: The Cochrane Library, MEDLINE and EMBASE were comprehensively searched to January 2005 for systematic reviews on aspects of diet and heart health. Reviews were included if they searched systematically for randomized controlled trials relating to diet and secondary prevention of CVD. Each review was critically appraised by at least two members of the UK Heart Health and Thoracic Dietitians Group. The quality and results of each review were discussed and summarized at a group meeting. RESULTS: Evidence-based strategies that reduce cardiovascular events in those with CVD include reduction in saturated fat and substitution with unsaturated fats. Individuals who have suffered a myocardial infarction may also benefit from adopting a Mediterranean type diet and increasing intake of omega 3 fats, but it is not clear whether they are beneficial for all patients with CVD. There is no systematic review evidence to support the use of antioxidant vitamins supplements, low glycaemic index diets, or homocysteine lowering therapies in this group. CONCLUSION: There remains good evidence that reducing saturated fat reduces morbidity in patients with CVD. This advice is consistent for most manifestations of CVD, with the addition of Mediterranean dietary advice and increased omega 3 fats for those who have had a myocardial infarction.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Dietética/normas , Guias de Prática Clínica como Assunto , Antioxidantes/administração & dosagem , Antioxidantes/uso terapêutico , Doenças Cardiovasculares/dietoterapia , Gorduras Insaturadas na Dieta/administração & dosagem , Gorduras Insaturadas na Dieta/uso terapêutico , Medicina Baseada em Evidências , Índice Glicêmico , Homocisteína/sangue , Humanos , Ensaios Clínicos Controlados Aleatórios como Assunto , Reino Unido
2.
J Orthod ; 32(2): 102-14, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15994984

RESUMO

OBJECTIVES: To evaluate the effectiveness of fluoride in preventing white spot lesion (WSL) demineralization during orthodontic treatment and compare all modes of fluoride delivery. DATA SOURCES: The search strategy for the review was carried out according to the standard Cochrane systematic review methodology. The following databases were searched for RCTs or CCTs: Cochrane Clinical Trials Register, Cochrane Oral Health Group Specialized Trials Register, MEDLINE and EMBASE. Inclusion and exclusion criteria were applied when considering studies to be included. Authors of trials were contacted for further data. DATA SELECTION: The primary outcome of the review was the presence or absence of WSL by patient at the end of treatment. Secondary outcomes included any quantitative assessment of enamel mineral loss or lesion depth. DATA EXTRACTION: Six reviewers independently, in duplicate, extracted data, including an assessment of the methodological quality of each trial. DATA SYNTHESIS: Fifteen trials provided data for this review, although none fulfilled all the methodological quality assessment criteria. One study found that a daily NaF mouthrinse reduced the severity of demineralization surrounding an orthodontic appliance (lesion depth difference -70.0 microm; 95% CI -118.2 to -21.8 microm). One study found that use of a glass ionomer cement (GIC) for bracket bonding reduced the prevalence of WSL (Peto OR 0.35; 95% CI 0.15-0.84) compared with a composite resin. None of the studies fulfilled all of the methodological quality assessment criteria. CONCLUSIONS: There is some evidence that the use of a daily NaF mouthrinse or a GIC for bonding brackets might reduce the occurrence and severity of WSL during orthodontic treatment. More high quality, clinical research is required into the different modes of delivering fluoride to the orthodontic patient.


Assuntos
Cariostáticos/uso terapêutico , Fluoretos/uso terapêutico , Aparelhos Ortodônticos , Desmineralização do Dente/prevenção & controle , Cariostáticos/administração & dosagem , Colagem Dentária , Cárie Dentária/prevenção & controle , Fluoretos/administração & dosagem , Cimentos de Ionômeros de Vidro/química , Humanos , Antissépticos Bucais/uso terapêutico
3.
J Hum Nutr Diet ; 17(4): 337-49, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15250843

RESUMO

AIM: To update dietetic guidelines summarizing the systematic review evidence on dietary advice to prevent further events in people with existing cardiovascular disease (CVD) (secondary prevention). METHODS: The Cochrane Library, MEDLINE and EMBASE were comprehensively searched to November 2002 for systematic reviews on aspects of diet and heart health. Reviews were included if they searched systematically for randomised controlled trials relating to diet and secondary prevention of CVD. Two members of the UK Heart Health and Thoracic Dietitians Group critically appraised each review. The quality and results of each review were discussed and summarized in a meeting of the whole group. RESULTS: Providing evidence-based dietary information (including increasing omega-3 fat intake) to all people who have had a myocardial infarction will save more lives than concentrating dietary advice on just those in need of weight loss or lipid lowering. The practice of prioritizing dietetic time in secondary prevention to those with raised lipids is out of date since the advent of statin therapy. However, effective dietary advice for those with angina, stroke, peripheral vascular disease or heart failure is less clear. CONCLUSION: There is good systematic review evidence that dietary advice to those with coronary heart disease can reduce mortality and morbidity as well as modify some risk factors. Dietary advice that does this most effectively should be prioritized.


Assuntos
Doenças Cardiovasculares/dietoterapia , Doenças Cardiovasculares/prevenção & controle , Dietética , Medicina Baseada em Evidências , Humanos , Guias de Prática Clínica como Assunto , Ensaios Clínicos Controlados Aleatórios como Assunto , Fatores de Risco , Reino Unido
6.
Can J Psychiatry ; 39(7): 392-8, 1994 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7987781

RESUMO

The objectives of this study were to examine the association of personality disorder with outcome of depression in older patients (age > or = 60) treated in a psychiatric day hospital for depression and to compare the clinical diagnosis of personality disorder at admission with the results of a semi-structured interview at follow-up. Sixty-four patients were followed up for a mean interval of 30 (13-49) months after admission to the psychiatric day hospital and the semi-structured interview, Social Support Scale, Life Events Inventory, Hamilton Depression Rating Scale and Mini-Mental State Examination administered by a psychiatrist blind to the details of the index admission. Forty-nine informants (a close friend or relative) were also interviewed using the semi-structured interview. Axis II diagnoses at the time of admission were determined from patient records. Personality disorder diagnoses were analysed according to DSM-III-R clusters. Twenty-one (33%) patients fulfilled criteria for personality disorder at admission and 23 (36%) at follow-up. There was strong agreement (k = 0.78) between patient and informant semi-structured interview results and moderate agreement (k = 0.41) between diagnosis at admission and at follow-up. Presence of a personality disorder, and in particular a cluster B personality disorder diagnosis was associated with chronic outcome of depression and with impaired social support. Personality is a significant factor in the outcome of depression in the elderly. It remains unclear whether current methods of assessment tap enduring characteristics, or manifestations of affective state.


Assuntos
Transtornos de Adaptação/terapia , Transtorno Bipolar/terapia , Transtorno Depressivo/terapia , Transtornos da Personalidade/terapia , Transtornos de Adaptação/psicologia , Idoso , Idoso de 80 Anos ou mais , Transtorno Bipolar/psicologia , Comorbidade , Hospital Dia , Transtorno Depressivo/psicologia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Determinação da Personalidade , Transtornos da Personalidade/psicologia , Resultado do Tratamento
8.
Gen Pharmacol ; 16(3): 297-8, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-4018547

RESUMO

A direct microscopic and microdensitometric examination was carried out on duodenal goblet-cells of non-fasted and fasted rats with and without carbenoxolone sodium treatment. The results of microdensitometric examination revealed a marked and significant increase of mucus production in the non-fasted and fasted rats pretreated for 2 hr with a single oral dose of carbenoxolone sodium at 100 mg/kg. Fasting alone also increased mucus production. On microscopic examination, the number of duodenal goblet-cells full of mucosubstances in the non-fasted and fasted rats receiving carbenoxolone sodium treatment was approximately 20% higher than in the controls.


Assuntos
Carbenoxolona/farmacologia , Ácido Glicirretínico/análogos & derivados , Mucosa Intestinal/citologia , Animais , Densitometria , Duodeno/citologia , Mucosa Intestinal/metabolismo , Masculino , Ratos , Ratos Endogâmicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...